Transcripts Larimar Therapeutics, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/07/2026			Varia. 5j.	Varia. 1 janv.
3,260 ^USD	+1,56 %		-10,93 %	-14,44 %

29/06	Transcript : Larimar Therapeutics, Inc. - Special Call
29/06	Larimar Therapeutics dépose le premier module de sa demande de licence biologique auprès de la FDA pour le nomlabofusp	MT

29/06	Transcript : Larimar Therapeutics, Inc. - Special Call
14/01	Transcript : Larimar Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:00 AM
29/09/25	Transcript : Larimar Therapeutics, Inc. - Special Call
23/06/25	Transcript : Larimar Therapeutics, Inc. - Special Call
16/12/24	Transcript : Larimar Therapeutics, Inc. - Special Call
12/02/24	Transcript : Larimar Therapeutics, Inc. - Special Call
25/07/23	Transcript : Larimar Therapeutics, Inc. - Special Call
15/05/23	Transcript : Larimar Therapeutics, Inc., Q1 2023 Earnings Call, May 15, 2023
14/09/22	Transcript : Larimar Therapeutics, Inc. - Special Call
09/09/21	Transcript : Larimar Therapeutics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 05:00 PM
11/05/21	Transcript : Larimar Therapeutics, Inc. - Special Call
18/12/19	Transcript : Chondrial Therapeutics, Inc., Zafgen, Inc. - M&A Call
11/03/19	Transcript : Zafgen, Inc., Q4 2018 Earnings Call, Mar 11, 2019
07/11/18	Transcript : Zafgen, Inc., Q3 2018 Earnings Call, Nov 07, 2018
07/08/18	Transcript : Zafgen, Inc., Q2 2018 Earnings Call, Aug 07, 2018
25/06/18	Transcript : Zafgen, Inc. - Special Call
09/05/18	Transcript : Zafgen, Inc. Presents at 43rd annual Deutsche Bank Healthcare Conference, May-09-2018 10:00 AM
08/05/18	Transcript : Zafgen, Inc., Q1 2018 Earnings Call, May 08, 2018